✦ LIBER ✦

Achievement of Therapeutic Goals Over 2 Years of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease

✍ Scribed by Deborah Elstein; Hadhami Ben Turkia; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Neerja Gupta; David Zahrieh; Eric Crombez; Ari Zimran

Book ID: 116989539
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 105
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2011.11.053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early achievement and maintenance of the

Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease

✍ D. Elstein; G.M. Cohn; N. Wang; M. Djordjevic; C. Brutaru; A. Zimran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Safety and efficacy of long-term enzyme

Safety and efficacy of long-term enzyme replacement therapy with velaglucerase alfa in patients with type 1 Gaucher disease transitioned from imiglucerase

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

A 7-year open-label study of clinical pa

A 7-year open-label study of clinical parameters and therapeutic goals in patients with type 1 Gaucher disease receiving treatment with velaglucerase alfa: Updating the long-term experience with velaglucerase alfa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Impact of velaglucerase alfa on bone mar

Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-Year follow-up

✍ Elstein, Deborah; Haims, Andrew H.; Zahrieh, David; Cohn, Gabriel M.; Zimran, Ar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Safety and Efficacy of Velaglucerase Alf

Safety and Efficacy of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease: 2 Years of Treatment in Phase III Trials and an Extension Study

✍ Ari Zimran; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Deborah E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Acute lymphoblastic leukemia in a patien

Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy

✍ Aditi Ranade; Sorin Selegean; Gagangeet Sandhu; Violette Ghali; Vijay P. Shah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Higher rates of venous thromboembolism for Black-Americans are likely due to lower serum ## 25-hydroxyvitamin D levels To the editor: The recent paper on disparities of thromboembolism in the United States concluded that heritability may be important in the etiology of venous thromboembolism amon